HOUSTON, Texas — August 22, 2014 — New, unpublished research on the omega-3 fatty acid, docosapentaenoic acid (DPA) will be presented at Experimental Biology 2014, a meeting held April 26-30 at the San Diego Convention Center. Results of two separate, unpublished studies will be presented by the co-author, Amanda Pepper-Yowell, doctoral candidate at Texas Tech University, Department of Animal and Food Science. Both studies were sponsored by Omega Protein Corporation and conducted by Texas Tech University.
Results from the first study found that purified eicosapentaenoic acid (EPA), DPA and docosahexaenoic acid (DHA), and menhaden-oil derived OmegaActiv Super DPA (from Nutegrity) improved serum lipid profiles in mice. The study also demonstrates that DPA decreases aortic plaque building, showing its potential role in the reduction of atherosclerosis. The study will be featured as part of a mini-symposium entitled “Medical Nutrition: Nutrition and Inflammation" on April 26 at 10:30 a.m., Room 29C.
Results from the second study on anti-inflammatory effects of DPA in cell culture model will be featured during poster session 1034.16 on April 29, from 1:45 to 2:45 p.m. in the exhibit halls. The study looks at the molecular mechanisms and anti-inflammatory actions of DPA.
Read the full story at Natural Products Insider